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MotionBackground and purpose: To characterize pancreatic tumor motion and to develop a gating scheme for
radiotherapy in pancreatic cancer.
Materials and methods: Two cine MRIs of 60 s each were performed in ﬁfteen pancreatic cancer patients,
one in sagittal direction and one in coronal direction. A Minimum Output Sum of Squared Error (MOSSE)
adaptive correlation ﬁlter was used to quantify tumor motion in craniocaudal, lateral and anteroposterior
directions. To develop a gating scheme, stability of the breathing phases was examined and a gating win-
dow assessment was created, incorporating tumor motion, treatment time and motion margins.
Results: The largest tumor motion was found in craniocaudal direction, with an average peak-to-peak
amplitude of 15 mm (range 6–34 mm). Amplitude of the tumor in the anteroposterior direction was
on average 5 mm (range 1–13 mm). The least motion was seen in lateral direction (average 3 mm, range
2–5 mm). The end exhale position was the most stable position in the breathing cycle and tumors spent
more time closer to the end exhale position than to the end inhale position. On average, a margin of 25%
of the maximum craniocaudal breathing amplitude was needed to achieve full target coverage with a
duty cycle of 50%. When reducing the duty cycle to 50%, a margin of 5 mm was sufﬁcient to cover the
target in 11 out of 15 patients.
Conclusion: Gated delivery for radiotherapy of pancreatic cancer is best performed around the end exhale
position as this is the most stable position in the breathing cycle. Considerable margin reduction can be
established at moderate duty cycles, yielding acceptable treatment efﬁciency. However, motion patterns
and amplitude do substantially differ between individual patients. Therefore, individual treatment strat-
egies should be considered for radiotherapy in pancreatic cancer.
 2014 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 111 (2014) 252–257Despite several advances in therapy, pancreatic cancer remains
one of the most aggressive tumors and has a very poor survival,
with an overall 5 year survival rate of approximately 5% [1]. Espe-
cially the high metastatic potential leads to this very low survival
[1]. Cure can only be reached by surgery. However, only 20% of pa-
tients that harbor only local disease can be operated. If not opera-
ble, the disease is considered locally advanced. For these patients
chemoradiation has been investigated. Unfortunately, up to now,
survival after chemoradiation remains poor [1,2]. Still, both
improvements in systemic therapy and radiation therapy may re-
sult in improved outcomes. In radiation therapy, especially high
ablative doses might result in an improvement of local control.
Also, the use of MRI has potential for treatment planning and guid-
ance. Radiotherapy can be associated with high gastrointestinaltoxicity since the pancreas is adjacent to radiosensitive organs
such as the duodenum and the stomach [3]. Moreover, the pan-
creas moves with respiration, which requires signiﬁcant treatment
margins to compensate for this motion [4–6]. The combination of a
large irradiated volume and the close vicinity of vital organs makes
pancreatic cancer challenging to irradiate up to curative dose
levels.
Dose escalation to the tumor is needed when the objective is lo-
cal control. However, this may lead to high toxicity. To overcome
toxicity while maintaining high tumor doses, treatment margins
must be minimized. As breathing is the major component of tumor
motion, it is an important contributor to a large treated volume.
Active motion compensation techniques such as tracked and gated
radiotherapy delivery are desired to minimize treated volumes
[4,5]. These techniques require image guidance to assess the target
position in time and thereby enable radiation delivery with high
precision and smaller margins. The use of tracking and gating for
radiotherapy of LAPC has been assessed by several groups and
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ity [7–13]. Most studies have been performed using the Cyber-
Knife, a system that allows tracked radiotherapy delivery [14].
Gated radiotherapy has the advantage that it can be delivered
with conventional linear accelerators, in contrast to tracked radio-
therapy delivery [15]. Respiratory gating involves irradiation
during a certain fraction of the respiratory cycle. When developing
a gating strategy, a trade-off has to be made between breathing
associated treatment margins required to obtain full target cover-
age and overall treatment time, as reducing margins increases
overall treatment time. In addition, timing of gating is essential,
i.e. at which phase of the breathing cycle gating is best performed.
The aim of this study was to develop an optimal gating
procedure for pancreatic cancer radiotherapy. For this purpose,
pancreatic tumor motion was quantiﬁed, based on cine magnetic
resonance imaging (MRI). Subsequently, the obtained motion pat-
terns were used to develop an optimal gating procedure, consisting
of a reproducible tumor position in the breathing cycle and a
patient speciﬁc trade-off between breathing amplitude, beam-on
time and treatment margins.Fig. 1. Angulation of the coronal scan plan in the principal motion direction of the
pancreas.Materials and methods
Patients
The study was approved by our local institutional review board.
All patients provided written informed consent. Fifteen patients
suspected of having pancreatic cancer based on computed tomog-
raphy and/or endoscopic ultrasound ﬁndings were scheduled for
MRI examination between January 2012 and January 2013.
Patients were scanned before surgical resection (Whipple’s resec-
tion or pyloric-preserving pancreatoduodenectomy) or before start
of palliative treatment. Patients were excluded if they met
exclusion criteria for MRI imaging according to our radiology
department protocol.Image acquisition
MRI scanning was performed on a 1.5 Tesla scanner (Achieva,
Philips, Best, The Netherlands) using a 16 channel phased array
torso coil. Patients drank 300 ml of tap water to increase contrast
between pancreas and duodenum and to minimize air in the
stomach.
In every patient, a respiratory triggered axial T2 weighted im-
age was acquired (TE/TR 80/588 ms, FOV 400  299  262 mm3,
slice thickness 3.5 mm, acquired voxel size 1.0  1.3  3.5 mm3,
reconstructed voxel size 0.8  0.8  3.5 mm3, FA 90, TSE 74,
SENSE factor 2, half scan factor 0.635). This scan served as an ana-
tomical reference to plan two cine MRIs: one sagittal scan and one
coronal scan. For the sagittal scan, the scan plane was positioned
through the center of the tumor which was identiﬁed on the axial
T2 weighted scan. The coronal plane was similarly set through the
center of the tumor. Since substantial out-of-plane motion was ob-
served in the ﬁrst three patients, the coronal plane was angulated
in the 12 subsequent patients. The angulation was chosen such
that the principal motion direction of the pancreas was positioned
in the scan plane, thereby minimizing out-of-plane motion. This
comes down to an angulation in the craniocaudal direction, rela-
tive to the left–right axis (Fig. 1). Scan parameters of the coronal
single slice SSFP sequence were as follows: TR/TE 2.8/1.40 ms, FA
50, FOV 450  450 mm2, slice thickness 7 mm, acquired voxel size
2.2  7.0  2.2 mm3 which were reconstructed on a grid with res-
olution 2.0  7.0  2.0 mm3. Sagittal imaging parameters were the
same, with exception of TR/TE 2.9/1.44 ms, FOV 320  301 mm2,
acquired voxel size 7.0  1.5  1.5 mm3 which was reconstructed
on a grid with resolution 7.0  1.4  1.4 mm3. Both cine MRIs werecollected over the course of 60 s, at a rate of 2 Hz. GTV delineation
was performed on the available imaging, using T2-weighted se-
quence and the cine-MRI.Motion characterization
An in-house developed validated software tool was used to
quantify the amount of motion observed on the two cine MRIs
[16]. This software tool was validated with Elastix software and
Optical Flow and showed to be non-inferior (see Electronic Appen-
dix Fig. A) [17,18] A Minimum Output Sum of Squared Error (MOS-
SE) adaptive correlation ﬁlter was used. This ﬁlter is capable of
tracking one point in a series of images, thereby being independent
of variations in intensity, scale and small non-rigid transformations
of the image [19]. Tumor motion was evaluated in craniocaudal,
lateral and anteroposterior directions. For target tracking, one
point at the inferior edge of the tumor and one at the superior edge
were chosen with high contrast between the tumor and the sur-
rounding structures on both the coronal and sagittal slides. The
excursions of these two points were averaged to calculate mean tu-
mor motion in anteroposterior and craniocaudal directions on the
sagittal scan. Left–right motion was determined in the same way
on the coronal scan. We chose to assess the craniocaudal motion
on the sagittal scan and not on the angulated coronal scan. As
the left–right motion showed to be negligible, the data from the
sagittal scan seemed to be more robust as no out of plane motion
is present on the sagittal cine MRI. The main motion trajectory of
the tumor was reconstructed from the craniocaudal and anteropos-
terior motion of the tumor as observed on the sagittal cine MRI, as
left–right motion was shown to be negligible.
Motion in each direction is reported as the M100% and M95%,
where M100% is distance between the most extreme excursions
measured over the duration of the entire scan (i.e., 60 s) and
includes outliers as hiccups, coughs and sneezes. M95% is a more
robust measure and is deﬁned as the bandwidth that includes
95% of the data points but excludes the 5th percentile most ex-
treme data points (2.5% at inspiration and 2.5% at expiration).
The stability and reproducibility of both the end inspiration po-
sition (EIP) and the end expiration position (EEP) were evaluated.
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is most efﬁcient to perform gating. Stability was expressed as 1
standard deviation (sd) of all peaks in inspiration or expiration,
respectively. This was calculated for both individual patients, as
well as for the average stability of all patients together. Subse-
quently, the ratio of EIP to EEP was calculated by dividing the time
spent closer to the EIP by the time spent closer to the EEP.Gating window
We deﬁne the Internal Gross Tumor Volume (IGTV) as the union
of all GTVs integrated over the beam-on time. We adapted this
from ICRU 62 where the Internal Target Volume (ITV) is considered
the volume encompassing the Clinical Target Volume (CTV) and
the Internal Margin (IM) [20]. In our analysis the IM is added to
the GTV. The size of the IGTV increases as the duty cycle (beam-
on time/total time) increases. At a duty cycle of 100% (i.e. continu-
ous irradiation), the IGTV covers all GTV positions over time. This
means that this IGTV is deﬁned as the GTV expanded with margins
equal to the maximal breathing excursions. GTV-to-IGTV margins
can be reduced at the cost of a reduced duty cycle. Ultimately, a
0 mm margin is established at a duty cycle of virtually zero. For
each patient, a probability density function (PDF) of the positions
of the GTV was created based on the motion trajectory. Trade-offs
between duty cycle and margins are determined by analyzing
these PDFs.Results
Patients
Fifteen patients were imaged using cine MRI (Fig. 2). Nine pa-
tients underwent pyloric-preserving pancreatoduodenectomy
after MRI imaging while six patients underwent palliative surgery
(double bypass surgery with or without experimental radiofre-
quency ablation procedure of the primary tumor). Three patients
were female, 12 patients were male. Mean age was 62 years (range
48–76 years). Sagittal cine MRIs were available in all 15 patients.
Useful coronal images were available in 12 patients, due to signif-
icant out-of-plane motion in three patients, thereby making accu-
rate motion analysis impossible.Fig. 2. Single frame of a mixed T1/T2 weighted cine MRI series of a pancreatic
cancer patient. The tumor is contoured in white. Tracking was performed at one
point at the inferior edge of the tumor, indicated with the X, and at one point at the
superior edge (not shown in this image).Characterization of tumor motion
The MOSSE adaptive correlation ﬁlter was successfully used to
quantify pancreatic tumor motion. It showed to be a very fast
and robust method, not requiring any adjustment during motion
quantiﬁcation. The largest tumor motion was found in craniocau-
dal direction, with an average M100% (complete peak-to-peak
amplitude) of 15 mm (range 6–34 mm, sd 9 mm) (Table 1, Fig. 3,
and Fig. B in Electronic Appendix). The M95% of craniocaudal mo-
tion was on average 13 mm (range 5–31 mm, sd 8 mm). M100% of
the tumor in the anteroposterior direction was on average 5 mm
(range 1–13 mm, sd 3 mm), mean M95% of anteroposterior motion
was 4 mm (range 1–12 mm, sd 3 mm). The least motion was seen
in lateral direction (mean M100% 3 mm, range 2–5 mm, sd 1 mm).
M95% in lateral direction was on average 2 mm (range 1–4 mm,
sd 1 mm). Difference in tumor motion between the superior and
inferior edge of the tumor was on average 0.4 mm in all directions.
The pancreatic tumor trajectory is depicted for all patients in
Fig. C in the Electronic Appendix. Because the left–right motion
was very small, the sagittal cine MRI showed the least out-of-plane
motion and thus shows in 2D the main direction of motion of the
tumor. The trajectory in craniocaudal and anteroposterior direction
was plotted. All tumor trajectories showed an angulation relative
to the left–right axis, with the cranial region angled toward poster-
ior and the caudal part angled toward anterior (Fig. C, Electronic
Appendix). The average angle was 11 (range 1–21, sd 6)
(Table 1).Gating strategy
The EEP showed to be a more reproducible position than the
EIP. The overall standard deviation in the CC direction of all EEPs
was 0.8 mm, whereas this was 1.9 mm for the EIPs (Table 1). All tu-
mors spent more time closer to the EEP than to the EIP, except for
the tumor of patient 14 (Fig. B, Electronic Appendix). On average,
70% of time the tumor was closer to the EEP than to the EIP (range
49–85%, sd 9%). These two ﬁndings support the fact that gating is
more time efﬁciently performed around the EEP than around EIP.Gating window
Two representations of a gating window assessment were
made. The ﬁrst is an assessment of the percentage beam-on time
that can be established by gating around the EEP with a margin
consisting of a percentage of the maximum breathing amplitude
in craniocaudal direction (Fig. 4). The second representation illus-
trates the percentage of beam-on time that can be established at
different margins (i.e. 3, 5, 7, or 9 mm) (Fig. 5).
Discussion
In this study, cine MRI provided insight into pancreatic tumor
motion. A MOSSE correlation ﬁlter was used to automatically track
tumor motion in coronal and sagittal planes within milliseconds
per frame.Tumor motion
The largest motion of the pancreatic tumors was observed in
craniocaudal direction, with an average motion of 15 mm. These
data are in line with previously described studies of pancreatic
tumor motion with cine MRI. Feng et al. and Bussels et al. demon-
strated a craniocaudal tumor motion of 20 mm and 24 mm, respec-
tively [4,5]. In our study, the M100% and the M95% motion
characteristics were presented. The relative difference between
the M100% and the M95% was 17% on average in craniocaudal
Table 1
Motion characteristics of patients.
Patient Tumor size (mm)a Tumor motion (mm) Stability (1 sd) (mm)b Degrees angulationc (95% CI)
CC AP EEP EIP
M100% M95% M100% M95%
1 11 26 20 9 7 0.8 2.9 12 (10–13)
2 22 34 31 9 8 1.3 1.6 17 (16–17)
3 12 28 25 13 12 1.2 2.6 21 (19–22)
4 25 23 20 5 4 1.6 2.1 13 (12–14)
5 25 9 7 3 2 0.5 1.2 7 (5–8)
6 53 7 6 1 1 0.1 1.4 6 (4–7)
7 21 11 10 4 3 0.6 1.3 6 (4–7)
8 35 10 8 4 3 0.8 1.2 8 (5–11)
9 25 10 9 3 2 0.4 1.6 12 (10–13)
10 50 7 6 2 2 0.1 0.9 15 (15–16)
11 n/a 9 7 3 1 0.4 0.8 10 (9–11)
12 64 8 6 4 3 0.3 1.3 19 (18–20)
13 50 6 5 1 1 0.4 0.6 6 (5–7)
14 n/a 18 13 3 2 1.4 1.3 1 (0–2)
15 n/a 22 16 8 6 0.5 4.2 7 (4–10)
Average (sd) 33
(17)
15
(9)
13
(8)
5
(3)
4
(3)
1 sd
0.8
1 sd
1.9
11 (6)
CC = craniocaudal direction; AP = anteroposterior direction.
a Largest tumor diameter in the axial plane. N/a = not available.
b Stability of end-exhale and end-inhale position, deﬁned as 1 standard deviation of all end-exhale or end-inhale positions present in 1 min expressed in mm.
c Degrees angulation of the trajectory of the pancreas in craniocaudal direction, relative to the left–right axis, where 0 is exactly the craniocaudal axis.
Fig. 3 (B) Tumor motion in three directions. All dots represent individual patients.
For each patient, the M100% and M95% are shown in craniocaudal (CC), anteropos-
terior (AP) and left–right (LR) direction.
Fig. 4. Extent of IGTV in relation to the beam-on time. As shown, at 50% beam-on
time, the required GTV-to-IGTV margin decreases to one quarter of the total
breathing amplitude.
Fig. 3. (A) Typical example of craniocaudal tumor motion over time (patient 9). The
peak-to-peak amplitude here is 14 mm. The end-exhale position (upper part) is
more reproducable than the end-inhale position (lower part).
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on average 18%. The results from this study demonstrated that tu-
mor motion is highly variable among pancreatic cancer patients.
The range of tumor motion was 6 mm to 34 mm in craniocaudal
direction. Nine patients showed a motion of 11 mm or less in cra-
niocaudal direction and six patients move 18 mm or more (Fig. 3B).
This implies that the majority of patients show a motion in a small
range and only a few patients exhibit a more pronounced motion.Motion management
These highly variable motion characteristics demonstrate the
need for an individual approach on how to address this motion.
At little motion, the use of active motion compensation techniques
leads to only a small margin reduction, and this does not outweigh
the effort of applying breathing control during radiotherapy [21].
Fig. 5. Duty cycles shown for different margins. Each dot represents an individual
patient.
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motion are hardly inﬂuenced by this tumor motion [22]. In clinical
practice, radiotherapy can be delivered without a motion manage-
ment strategy when tumors show limited motion on cine MRI. In
contrast, when patients with large tumor amplitudes are treated
without motion management techniques, the whole amplitude
needs to be added to the GTV to establish full target coverage in
all phases. This leads to large treated volumes with sometimes
inacceptable toxicity. Therefore, the use of a sophisticated motion
management strategy is recommended if tumor motion is more
pronounced. Tracked radiotherapy delivery is preferable when
choosing a motion management technique, as this is the most time
efﬁcient technique. However, gated radiotherapy is a good alterna-
tive when tracking is not possible and its main advantage is that
gating is feasible with widely available conventional linear acceler-
ators. Gated radiotherapy is not necessary when pancreatic tumor
motion is less than 8 mm according to Tai et al. This is based on a
95% or more overlap between ITVs at different phases of the 4D CT
when tumor motion is less than 8 mm [23]. At a tumor motion of
8 mm or more, gated radiotherapy is advisable.
In this study the end expiration position has shown to be the
most stable position and also the position in which the tumors
spend a high proportion of time. This is in line with literature, as
Coolens et al. showed that the phases around exhale have the
smallest variation in both amplitude and phase [24]. As such we
developed a gating scheme around the stable EEP where the duty
cycle is balanced against a one-sided treatment margin. In addi-
tion, Taniguchi et al. showed that the EEP is the preferred position
for gated radiotherapy, as the dose in organs at risk is lower when
gating around EEP than when gating around EIP [25]. Full target
coverage is obtained with a one-sided caudal margin of on average
only a quarter of the breathing amplitude at a 50% duty cycle
(Fig. 4). However, a large inter-patient variation does exist as the
required margin varies between 13% and 49% at this 50% duty cycle
level, mainly due to a difference in stability of EEP. When translat-
ing this to absolute margins, a margin of 5 mm is sufﬁcient for 11
out of 15 patients at a duty cycle of at least 50% to reach full target
coverage (Fig. 5). At lower duty cycles the margin can be further re-
duced to 3 mm for 11 out of 15 patients at a beam on time of 25%.
As the mean tumor amplitude in craniocaudal direction was15 mm, this demonstrates that gating around the EEP considerably
decreases the treatment margins at acceptable duty cycles for the
majority of patients.
However, 4 out of 15 patients exhibited irregularities in EEP, even
with standard deviations of 1.2 mm or higher. Therefore, gating
schemes around the EEP seem suboptimal for these patients for
two reasons. First, accurate patient setup is problematic as the insta-
bility of the EEP hinders deﬁnition of the EEP. Secondly, duty cycles
may become extremely short in combination with treatment mar-
gins of 5 mm or smaller, leading to unacceptably long treatment
times. For these patients, gating at the midvent position may lead
to smaller margins at the same duty cycles. Though, the velocity of
tumors is highest around themidventposition, possiblyneutralizing
the potential beneﬁt of smaller margins. The shape of the motion
PDF could impact where gating might be optimal on an individual
basis. This againdemonstrates that an individual approach is needed
for gated radiotherapy delivery in pancreatic cancer patients.
Another way of increasing treatment efﬁciency is by actively
reducing tumor motion. This may be accomplished by using an
abdominal compression device (ACD). Studies in patients with liver
tumors revealed that tumor motion and treated volumes can be re-
duced by using an ACD [26,27]. The pancreas and liver are situated
close to each other, and this suggests that in pancreatic cancer pa-
tients abdominal compression may also decrease motion. This may
lead to such a reduction of motion that no motion management
strategy is needed anymore or to higher duty cycles when per-
forming gated radiotherapy.
In this study we demonstrated that individual breathing pat-
terns vary substantially among patients and that its pretreatment
assessment is very useful and functional in setting up the optimal
gating scheme. 4D CT is a widely used technology to analyze tumor
positions in moving tumors. However, 4D CT has some drawbacks.
CT has a poor soft tissue contrast, and accurate tumor demarcation
is therefore difﬁcult. Moreover, motion characterization with 4D
CT is generally based on retrospective sorting of oversampled
images based on the corresponding breathing signals. This means
that the fourth dimension is generally not time but phase. In addi-
tion, imaging artifacts are common due to breathing irregularities.
We demonstrated that cine MRI is a more convenient method to
provide insight in tumor motion and also motion of organs at risk.
Due to the high soft tissue contrast semi-automatic quantiﬁcation
of the tumor motion using a correlation ﬁlter was achieved in all
patients without employing ﬁducial markers that could easily be
extended to motion characterization of organs at risk as well.
Moreover, it is possible to study multiple subsequent breathing cy-
cles, therewith enabling to quantify the reproducibility of the
breathing pattern over an arbitrary time span. Although outside
the scope of this study, the day-to-day variation of the breathing
pattern could additionally be examined as the use of MRI is free
of ionizing radiation.
This study has several limitations. The patients in this study had
(palliative) surgery as their primary treatment and were not irradi-
ated. Therefore no validation with pathology was available. The
delineations were only performed on T2-weighted images and
cine-MRI. For delineation also other sequences might become rel-
evant, but were not used in this study. We believe this GTV uncer-
tainty is not relevant to estimate tumor movement in this study, as
visually, on cine-MRI the tumor and surrounding tissues move in
the same way.
In this study we chose an arbitrary 2.5% to deﬁne M95%. Better
measures might be related to the proposed gated state. The
average angle reported is smaller than the angle determined from
the ratio of motion either at the extremes or at the 95% levels. It
should be noted that the sample size is too small to exclude a
non-Gaussian distribution and patient selection might not be
representative for the entire population.
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terns and therefore also gating strategies, like tumor size, involve-
ment of vessels and the presence of a stent. In addition, motion
patterns may change over time by changing anatomy or tumor
shrinkage. Therefore, motion must be monitored during the course
of radiotherapy.
Although cine MR is shown to be useful and effective for pre-
treatment tumor motion characterization, we currently depend
on a kV imaging techniques in combination with ﬁducial markers
when it comes to gated treatment delivery. However, several
groups are developing external beam treatment systems with an
integrated MR scanner [28–31]. These systems potentially allow
online MR imaging during treatment and as our MOSSE adaptation
ﬁlter turned out to be fast and robust, this may be online used to
generate a gating signal.
Conclusion
Pancreatic tumor motion was quantiﬁed with a MOSSE adaptive
correlation ﬁlter applied on different cine MRIs. Tumor motion was
shown to be extensive, with a maximummotion seen in craniocau-
dal direction (15 mm). When using gated radiotherapy, gating is
best performed around the end expiration position, as this is the
position where tumors spend most of the time and this is the most
stable position in the breathing cycle. A duty cycle of 50% leads, on
average, to a reduction of the IGTV to 25% of the maximum cranio-
caudal breathing amplitude to achieve full target coverage when
gating around expiration. However, between different patients,
motion patterns and amplitude do substantially differ and conse-
quently the range of motion margins needed is very extensive.
Therefore, individual treatment strategies are essential in radio-
therapy of pancreatic cancer.
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.radonc.2014.
03.002.
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